Aziyo Biologics Inc. (AZYO)
NASDAQ: AZYO
· Real-Time Price · USD
1.49
0.03 (2.05%)
At close: Sep 06, 2023, 9:59 PM
Aziyo Biologics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -9.61M | -3.93M | -35.04M | 1.29M | -28.18M | -312K | -10.62M | -7.97M | -5.44M | -9.91M | -9.4M | -8.15M | -9.06M | -8.32M | -2.38M | -5.07M |
Depreciation & Amortization | 892K | 868K | 1.55M | 862K | 862K | n/a | 954K | 947K | 937K | 933K | 934K | 929K | 933K | 932K | 932K | 933K |
Stock-Based Compensation | 1.15M | 1.21M | 6.52M | 1.77M | 2.71M | n/a | 687K | 684K | 774K | 298K | 1.47M | 1.1M | 973K | 1M | 885K | 677K |
Other Working Capital | n/a | n/a | -1.57M | -5.09M | n/a | n/a | 144K | 1.43M | -2.91M | 3.16M | 136K | 68K | 273K | -145K | 1.23M | -713K |
Other Non-Cash Items | -659K | -7.03M | 16.24M | -2.69M | n/a | 312K | 2.86M | 849K | -3.98M | 1.01M | 673K | 675K | 697K | 692K | -2.34M | 693K |
Deferred Income Tax | n/a | n/a | -834K | n/a | -11K | n/a | 834K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -3.03M | n/a |
Change in Working Capital | n/a | n/a | -3.22M | -4.66M | n/a | n/a | 2.9M | 328K | 2.47M | 2.15M | 3M | -1.91M | 74K | 2.59M | 2.12M | -2.41M |
Operating Cash Flow | -8.23M | -8.88M | -14.79M | -3.43M | n/a | -312K | -2.39M | -5.17M | -5.25M | -5.51M | -3.32M | -7.35M | -6.39M | -3.1M | -787K | -5.17M |
Capital Expenditures | n/a | n/a | 267K | 13K | n/a | n/a | -85K | -182K | -134K | -117K | -255K | -34K | -25K | -97K | -116K | -131K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -114K | -278K | -474K | -560K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -114K | -278K | -207K | -547K | n/a | n/a | -85K | -182K | -134K | -117K | -255K | -34K | -25K | -97K | -116K | -131K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -516K | 13.28M | 16.96M | 11.53M | n/a | n/a | -19K | 148K | 14.27M | -2.78M | -2.08M | -869K | 14.21M | -2.55M | -1.23M | -3.73M |
Financial Cash Flow | -516K | 13.28M | 16.96M | 11.53M | n/a | n/a | -19K | 148K | 14.27M | -2.78M | -2.08M | -869K | 14.21M | -2.55M | -1.23M | -3.73M |
Net Cash Flow | -8.86M | 4.12M | 13.55M | 7.55M | n/a | -312K | -2.49M | -5.2M | 8.89M | -8.41M | -5.66M | -8.25M | 7.8M | -5.74M | -2.13M | -9.03M |
Free Cash Flow | -8.23M | -8.88M | -14.52M | -3.41M | n/a | -312K | -2.47M | -5.35M | -5.38M | -5.63M | -3.58M | -7.38M | -6.41M | -3.19M | -903K | -5.3M |